SparkGene Biotechnology, founded by @UCLAengineering doctoral alumnus Binru (Andy) Chen (Ph.D. ’23), democratizes cell therapies with innovative microfluidic technology. SparkGene Biotechnology was awarded $20,000 in investment capital at the 2023 Venture Accelerator Innovation Showcase.

UCLA Affiliations: UCLA Anderson Easton Innovation Challenge, Knapp Venture Competition, UCLA School of Law Sandler Prize (@UCLA_Law); UCLA Technology Development Group (@uclatdg) Venture Accelerator Activate Program

Discover the dynamic startups imagined and developed by UCLA entrepreneurs: [ Ссылка ]

#geneediting #medicine #FDA

свернуть